Assessment of the long-term effect of vaccination on transmission of infectious bovine rhinotracheitis virus in cattle herds hyperimmunized with glycoprotein E-deleted marker vaccine
Ampe; Duchateau, L.; Speybroeck, N.et al.
2012 • In American Journal of Veterinary Research, 73, p. 1787-1793
Thiry, Etienne ; Université de Liège - ULiège > Département des maladies infectieuses et parasitaires > Virologie vétérinaire et maladies virales animales
Dispas, Marc
Language :
English
Title :
Assessment of the long-term effect of vaccination on transmission of infectious bovine rhinotracheitis virus in cattle herds hyperimmunized with glycoprotein E-deleted marker vaccine
Publication date :
2012
Journal title :
American Journal of Veterinary Research
ISSN :
0002-9645
eISSN :
1943-5681
Publisher :
American Veterinary Medical Association, Schaumburg, United States - Illinois
Lemaire M, Pastoret P-P, Thiry E. Le contrôle de l'infection par le virus de la rhinotrachéite infectieuse bovine. Ann Med Vet 1994;138:167-180.
Muylkens B, Thiry J, Kirten P, et al. Bovine herpesvirus 1 infection and infectious bovine rhinotracheitis. Vet Res 2007;38:181-209.
Boelaert F, Biront P, Soumare B, et al. Prevalence of bovine herpesvirus-1 in the Belgian cattle population. Prev Vet Med 2000;45:285-295.
Van Wuijckhuise L, Bosch JC, Franken P, et al. Epidemiological characteristics of bovine herpesvirus 1 infections determined by bulk milk testing of all Dutch dairy herds. Vet Rec 1998;142:181-184.
Kaashoek MJ, Moerman A, Madic J, et al. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type-1 is an efficacious and safe vaccine. Vaccine 1994;12:439-444.
Kaashoek MJ, Van Oirschot JT. Early immunity induced by a live gE-negative bovine herpesvirus 1 marker vaccine. Vet Microbiol 1996;53:191-197.
Van Oirschot JT, Kaashoek MJ, Maris-Veldhuis MA, et al. An enzyme-linked immunosorbent assay to detect antibodies against glycoprotein gE of bovine herpesvirus 1 allows differentiation between infected and vaccinated cattle. J Virol Meth 1997;67:23-34.
Mars MH, De Jong MCM, Franken P, et al. Efficacy of a live glycoprotein E-negative bovine herpesvirus 1 vaccine in cattle in the field. Vaccine 2001;19:1924-1930.
Bosch J, De Jong M, Franken P, et al. An inactivated gE-negative marker vaccine and an experimental gD-subunit vaccine reduce the incidence of bovine herpesvirus 1 infections in the field. Vaccine 1998;16:265-271.
Barkema H, Bartels C, Van Wuijckhuise L, et al. Outbreak of bovine virus diarrhea on Dutch dairy farms induced by a bovine herpesvirus 1 marker vaccine contaminated with bovine viral diarrhea virus type 2. Tijdschr Diergeneeskd 2001;126:158-165.
Makoschey B, Zehle H-H, Bussacchini M, et al. Efficacy of a live bovine herpesvirus type 1 marker vaccine under field conditions in three countries. Vet Rec 2007;161:295-298.
Kerkhofs P, Renjifo X, Toussaint J-F, et al. Enhancement of the immune response and virological protection of calves against bovine herpesvirus-1 with an inactivated gE-deleted vaccine. Vet Rec 2003;152:681-686.
Van Schaik G, Dijkhuizen AA, Huirne RBM, et al. Risk factors for existence of BHV-1 antibodies on nonvaccinating Dutch dairy farms. Prev Vet Med 1998;34:125-136.
Kramps JA, Perrin B, Edwards S, et al. A European inter-laboratory trial to evaluate the reliability of serological diagnosis of bovine herpesvirus 1 infections. Vet Microbiol 1996;53:153-161.
Wentinck GH, Van Oirschot JT, Verhoeff J. Risk of infection with bovine herpesvirus 1 (BHV1): a review. Vet Q 1993;15:30-33.
Duchateau L, Janssen P. Frailty distributions. In: Duchateau L, Janssen P, eds. The frailty model. New York: Springer, 2008;117-197.
Diekmann O, Heesterbeek J, Metz J. On the definition and the computation of the basic reproduction ratio (R0) in models for infectious diseases in heterogeneous populations. J Math Biol 1990;28:365-382.
Dispas M, Schynts F, Lemaire M, et al. Isolation of a glycoprotein E deleted bovine herpesvirus-1 strain in the field. Vet Rec 2003;152:209-212.
Muylkens B, Meurens F, Schynts F, et al. Intraspecific bovine herpesvirus 1 recombinants carrying glycoprotein E deletion as a vaccine marker are virulent in cattle. J Gen Virol 2006;87:2149-2154.
Djulbegovic B, Clarke M. Scientific and ethical issues in equivalence trials. JAMA 2001;9:1206-1208.
Pocock SJ. The pros and cons of noninferiority trials. Fundam Clin Pharmacol 2003;17:483-490.
Bosch JC, Kaashoek MJ, van Oirschot JT. Inactivated bovine herpesvirus 1 marker vaccines are more efficacious in reducing virus excretion after reactivation than a live marker vaccine. Vaccine 1997;15:1512-1547.
